{"id":"W4380149121","doi":"10.1016/j.jval.2023.03.1488","title":"HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Commercialization; Medicine; Disease; Health technology; Intensive care medicine; Health care; Business; Political science; Internal medicine; Marketing","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006423885,0.0002566382,0.0004951842,0.001127175,0.001372946,0.004702546,0.001283181,0.001947797,0.005691177],"category_scores_gemma":[0.02983936,0.0002149869,0.000676555,0.001913609,0.0008301736,0.001768485,0.001193773,0.003766136,0.0004118597],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05101043,"about_ca_system_score_gemma":0.1055587,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9789261,"about_ca_topic_score_gemma":0.9875342,"domain_scores_codex":[0.9961837,0.0005517155,0.0001886949,0.0002844789,0.001521387,0.001269985],"domain_scores_gemma":[0.9802665,0.004959601,0.002386081,0.0002532197,0.007079594,0.005055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002498975,0.0005489902,0.3501325,0.0006199027,0.0005928837,0.0012159,0.001784017,0.01637257,0.0008985267,0.04347852,0.377653,0.2042043],"study_design_scores_gemma":[0.0009618515,0.0005307631,0.6185,0.001565608,0.0005251977,0.0003702328,0.004558941,0.07298313,0.001294763,0.02859863,0.2697664,0.0003443858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3189529,0.01324911,0.003279971,0.5858931,0.001199235,0.0003120488,0.02632168,0.0001540697,0.05063783],"genre_scores_gemma":[0.9631159,0.003403074,0.002753361,0.01720278,0.0004593033,0.000078448,0.004551676,0.0000613728,0.008374141],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9489896,"threshold_uncertainty_score":0.3701083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5703338503532178,"score_gpt":0.4850943260995614,"score_spread":0.08523952425365638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}